Category: Approval/Launch Region: Asia · Korea, Democratic People's Republic of Company: Eisai Korea Inc

Eisai Files Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimers Disease In South Korea

Eisai Files Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimers Disease In South Korea
Lecanemab (Brand Name In The U.S.: Leqembi

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!